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Introduction: Clinical, laboratory and imaging ﬁndings in patients with multidrug resistant-
tuberculosis  (MDR-TB) and non-tuberculosis mycobacterium (NTM) are similar, and the
majority  of these patients present with positive smear for Acid Fast Bacilli (ADB) and no
response  to ﬁrst line anti-TB treatment, so sputum culture and PCR are necessary, especially
in  NTM.
Objective: In this study we  evaluate more details of imaging ﬁndings to help earlier diagnosis
of  pathogens.
Materials and methods: 66 patients with positive smear for AFB and no response to ﬁrst line
anti-TB drugs were divided into two groups by PCR and culture: MDR-TB (43 patients) and
NTM  (23 patients). Age, sex, history of anti-TB treatment, smoking and CT-scan ﬁndings
(parenchymal,  pleural and mediastinal variables) by details and lobar distribution were
analyzed.
Results:  Mean age of NTM patients was slightly higher (52 versus 45) and there is no sig-
niﬁcant  difference in sex and smoking. In MDR-TB group, history of anti-TB treatment and
evidence  of chronic pulmonary disease such as calciﬁed and ﬁbrodestructed parenchyma,
volume  loss and pleural thickening were higher signiﬁcantly. Cavities in MDR-TB were thick-
wall in the background of consolidation, while NTM cavities were more thin-walled with
adjacent  satellite nodules in same segment or lobe. Prevalence of bronchiectasis was  similar
in  both groups, while bronchiectasis in MDR-TB group was in ﬁbrobronchiectatic background
in  upper lobes, and in NTM group the distribution was more uniform with slightly middle
lobes  predominance. Prevalence and distribution of nodular inﬁltrations were similar more
in  Tree in Buds and scattered pattern. Calciﬁed or non-calciﬁed lymph nodes and also pleu-
ral  changes were more frequent in MDR-TB but prevalence of lymphadenopathy was  mildlyhigher  in NTM.
ist wiConclusion: A check-lgroups.
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Table 1 – Comparing variables.
Variable NTM MDR-TB p-value
Sex 34.8 male
65.2 female
58  male
42 female
0.07
Age  (mean age) 51.57 44.86 –
History  of smoking 26.1 20.9 0.6
Previous  treatment 56.5 83.7 0.01*
NTM, non-tuberculous mycobacteria; MDR-TB, multidrug-resistant
TB.  All numbers show percentage within each group (MDR & NTM
ables.  Variables were  compared by the chi-square test and
p-value  less than 0.05 was  considered statistically signiﬁcant.
Data  analysis was  carried out using SPSS version 17.
Table 2 – Chest CT scan ﬁndings.
CT ﬁndings NTM MDR-TB p-value
Parenchyma
Fibrodestruction 17.4 65.1 0.001*
Calciﬁed parenchyma 8.7 39.5 0.008*
Volume loss 17.4 53.5 0.004*
Cavitary lesion 69.6 76.7 0.5
Multiple cavities 56.5 60.5 0.7
Single cavity 13 14 0.9
Thin wall cavity 65.2 46.5 0.1
Thick wall cavity 26.1 58.1 0.01*
Cavitary consolidation 0 44.2 0.001*
Cavity + satellite nodules 39.1 9.3 0.004*
Nodular inﬁltration 69.6 76.7 0.5
Tree-in-bud 47.8  46.5 0.9
Scattered 47.8 60.54 0.3
Labor 13 9.3 0.6
Cavitary nodules 21.7 27.9 0.6
Macro nodules 43.5 25.6 0.1
Miliary pattern 0 0 –
Bronchiectasis 87 79 0.4
PBWT 43.5 58.1 0.2
Consolidation 34.8 37.2 0.8
Emphysema 4.3 7 0.6
Mediastinum
Calciﬁed lymph node 52.8 88.4 0.001*
Non calciﬁed lymph node 0 14 0.06
LAP (hilar & mediastinal) 26 11.6 0.2
Pericardium pleura
Pleural  effusion 4.3 20.9 0.07
Loculated pleural effusion 4.3 11.6 0.3
Pleural thickening 21.7 58.1 0.005*
Pleural calciﬁcation 0 2.3 0.4
Pericardial effusion & thickening 4.3 4.7 0.9138  b r a z j i n f e c t d 
Introduction
Tuberculosis (TB) is rated as second cause of death among
infectious disease following AIDS.1 In 2009 about 1.7 million
people  died from tuberculosis and multidrug resistant-
TB  (MDR-TB) itself was  responsible for 150,000 deaths in
2008.2 95% of pulmonary mycobacterial infections are caused
by  mycobacterium tuberculosis (MTB) and 5% by non-
tuberculous mycobacteria (NTM).3
As a consequence of the increasing AIDS incidence, preva-
lence  of MDR-TB and also non-tuberculous mycobacterial
infection are rising. On the other hand incomplete treatment
of  TB makes drug resistance more  likely by spot mutation in
mycobacterium genome. Also, immunosuppressed patients
like  who are recipient of solid organ or myelolymphopro-
liferative cells transplant and patients with lymphoma or
leukemia  and those under corticosteroid treatment are more
susceptible  to NTM. However NTM can be pathogenic in nor-
mal  hosts or in those with pulmonary disease.1 According to
the  deﬁnition released by WHO,  MDR-TB is referred to infec-
tions  caused by mycobacterium resistant to isoniazid and
rifampin.2
NTM is an environmental organism that lives in soil and
water  and its infection has different clinical manifestations
in patients. However, the lung seems to be the most common
site  of involvement, same as MTB.4 Since pathologic ﬁndings
of  NTM and MTB  regarding granulomatous inﬂammation and
even  cavity are very similar, it is difﬁcult to distinguish them
from  pulmonary TB. Also, ﬁndings in chest radiography and
CT-scan  are similar.5 Diagnosis of NTM and MTB  begins with
isolating  acid fast bacilli (AFB) from sputum but to conﬁrm
diagnosis and recognize species sputum culture is required
which  often takes at least 2–3 weeks, especially in the case of
NTM.6,7 Similar laboratory, radiological and clinical ﬁndings
in  MTB  and NTM, and also failure to ﬁrst line anti-TB treat-
ment  in MDR-TB and NTM lead to misdiagnosis and delayed
treatment with increased chance of pathogen spread.5,8 The
focus  of this study is to provide more  details of radiological CT-
scan ﬁndings in these two groups of mycobacterial infection
to  reach earlier diagnosis of species.
Materials  and  methods
This retrospective study evaluates suspected patients of MDR-
TB  referred to Masih Daneshvari hospital admitted between
2006  and 2010. First sputum samples were  positive for AFB
and  after failure to ﬁrst line anti-TB treatment, patients were
referred  to the hospital as suspicious of MDR-TB. 66 patients
were  enrolled in the study, all anti-HIV negative. After per-
forming  PCR, MDR-TB was  conﬁrmed in 43, and NTM in 23
cases.  Spiral CT-scan without contrast was  performed in all
patients  during hospital admission and 35 imaging factors
were  compared between the two groups, reported as seen or
not seen in each CT-scan. Initially both groups were assessed
in  terms of age, gender, history of smoking and anti-TB treat-
ment.  Chest CT-scans were  observed by two radiologists,
experts in chest radiography, unaware of the mycobacterium
species, and results were  reported by consensus. Tables 1 and 2groups).
∗ MDR-TB > NTM.
demonstrate variables and results. Additionally, ﬁve variables
including  bronchiectasia, peribronchial wall thickening, sin-
gle  cavity, multiple cavity, and consolidation were evaluated
in  terms of lobar distribution (in six lobes) (Table 3).
Descriptive statistical analysis was conducted for all vari-NTM, non-tuberculous mycobacteria; MDR-TB, multidrug-resistant
TB;  PBWT, peribronchial wall thickening; LAP, lymphadenopathy. All
numbers show percentage within each group (MDR & NTM groups).
∗ MDR-TB > NTM.
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Table 3 – Lobar distribution of parenchymal lesions.
MDR (n = 43), NTM (n = 23) RUL RML LUL Lin LLL RUL
Bronchiectasis
MDR 68 26 21 42 30 28
NTM 31 57 44 22 39 39
p-value 0.004* 0.01** 0.05** 0.1 0.4 0.3
Peribronchial thickening
MDR  42 19 16 26 19 21
NTM 13 35 18 4 13 18
p-value 0.01* 0.1 0.9 0.03* 0.5 0.7
Single cavity
MDR  5 0 0 5 0 5
NTM 9 0 0 4 0 0
p-value 0.5 – – 0.9 – –
Multiple cavities
MDR  51 9 23 44 19 16
NTM 26 22 26 48 26 31
p-value 0.05* 0.1 0.7 0.7 0.4 0.1
Consolidation
MDR 30 14 23 16 12 14
NTM 13 26 9 4 9 18
p-value 0.1 0.2 0.1 0.1 0.7 0.7
NTM, non-tuberculous mycobacteria; MDR-TB, multidrug-resistant TB; RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LUL,
left upper lobe; lin, lingular segment; LLL, left lower lobe. All numbers show percentage within each group (MDR & NTM groups).
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Fig. 1 – Fibrocavitary changes and volume loss of right lung∗ MDR-TB > NTM.
∗∗ NTM > MDR-TB.
This study was  approved by the ethic committee of Masih
aneshvari Hospital.
esults
fter performing PCR and culture for 66 patients suspected of
DR-TB,  43 cases proved to be MDR-TB and 23 cases NTM.
emographic characteristics and CT-scan changes are pre-
ented  in Tables 1 and 2. Mean age of NTM was  shortly higher
han  MDR-TB (52 versus 45 years). There were  no signiﬁcant
ifferences in terms of gender and smoking history; however,
istory  of previous anti-TB treatment was  signiﬁcantly more
ommon  in the MDR  group.
Most  common CT-scan ﬁndings in MDR  patients in order
f  prevalence were:  hilar or mediastinal calciﬁed lymph node,
ronchiectasis, nodular inﬁltration and cavity, and ﬁbrode-
tructive  changes. In the NTM group the ﬁndings were
ronchiectasis, nodular inﬁltration and cavity, and hilar or
ediastinal  calciﬁed lymph node.
Chronic changes like ﬁbrodestruction, calciﬁed
arenchyma, volume loss, and pleural thickening were
igniﬁcantly more  common in MDR-TB group (Fig. 1).
Cavities  were  more  prevalent in MDR-TB and they appeared
ostly  in multiple patterns in both groups.
Thick wall cavities were signiﬁcantly more  common in the
DR  group, whereas thin wall cavities slightly more  common
n  the NTM group (Fig. 2). From another point of view, cavi-
ies  of the MDR  group mostly appear as cavitary consolidation
hile  in the NTM group as cavities with satellite nodules, with
igniﬁcant  difference between these two groups (Fig. 3). Mul-
iple  cavities in the NTM group have more  homogenous lobarapex.
distribution whereas in the MDR group cavities were  signiﬁ-
cantly  more  common in the right upper lobe (RUL) than in the
middle  and inferior lobes. Also multiple cavities in RUL were
notably  more  frequent in MDR group than NTM group.
No  considerable difference in shape and prevalence of
nodular  inﬁltration were detected between these groups; how-
ever, nodules often presented in the form of Tree in Buds (TIB)
and  scattered pattern (Fig. 4).
There was  no signiﬁcant difference associated to
bronchiectasis and PWBT prevalence between these groups.
However,  in the MDR group bronchiectasis and PWBT were
more  common in superior lobes, and RUL involvement was
signiﬁcantly different from middle and inferior lobes. In
NTM  group middle and inferior lobes were  more  affected
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Fig. 2 – Thick wall cavity (left) and thin wall cavity (right);
note  nodular inﬁltration adjacent to cavities.
Fig. 3 – Cavitary consolidation (left) and cavity with satellite
nodules  (right).
by bronchiectasis and PWBT, but not signiﬁcantly (Fig. 5).
In  terms of lobar involvement, bronchiectasis in right mid-
dle  lobe (RML) and right lower lobe (RLL) strongly suggests
NTM,  and bronchiectasis in RUL and PBWT in superior lobes
strongly  supports diagnosis of MDR-TB.
Prevalence and distribution pattern of consolidation
between the two groups were not notably different.All changes related to pleura were  more  frequent in MDR-
TB,  but only higher prevalence of pleural thickening in MDR-TB
showed  signiﬁcant difference. 4.3% of NTM patients had
Fig. 4 – Nodular inﬁltration and bronchiectasis in NTM (left)
and  Tree in Buds (right). 1 3;1  7(2):137–142
pleural effusion, all loculated, while pleural effusion occurred
in  21% of MDR-TB cases, with almost 12% being loculated
(Fig.  6). Hilar and mediastinal lymph node involvement, cal-
ciﬁed  or non-calciﬁed were  more  common in MDR-TB but LAP
(lymph  node with short axis > 10 mm)  were more  prevalent in
NTM cases than MDR-TB cases.
Discussion
Comparison of chest imaging between the groups of MDR-TB
and  NTM in early stages of diagnosis can differentiate these
two  groups. Unfortunately, there are not enough studies com-
paring  imaging ﬁndings of NTM and MTB, especially MDR-TB,
so  we  hope this study to contribute to the ﬁeld. As in similar
studies, mean age of patients with NTM was  higher.7,9 Among
patients  with AFB-positive sputum age can be a predictive fac-
tor for NTM disease.9 There was  no signiﬁcant difference in
terms  of gender, but history of anti-TB treatment in MDR-TB
patients  was  more  common compared with NTM patients and
these  results, associated with gender and history of anti-TB
treatment, are reported in another study comparing NTM and
drug-sensitive  TB.9
In this study there were no signiﬁcant differences between
bronchiectasis and PWBT incidence between these two
groups;  however, middle lobes (RML and lingula) in NTM group
and  superior lobes, specially RUL, in MDR-TB cases were  more
affected.  It seems that bronchiectasis in the MDR-TB group
often  happens in the presence of ﬁbro bronchiectatic and
ﬁbrodestructive changes which clariﬁes why superior lobes
are  more  affected.
In  1999 Park and his colleagues showed that peribronchial
wall thickening in right and left superior lobes was  seen more
often  in MDR-TB. Proximal airways wall thickening in TB
patients  is very prominent10 and is seen as decreased lumen
width  with irregular bronchial wall thickening which can lead
to  bronchiectasis particularly in superior lobes.11 We had a
similar  ﬁnding in this study as well. Nonetheless, it is still an
issue  of controversy if bronchiectasis is a predisposing factor
for  NTM or a consequence of that. Meanwhile some ﬁndings
show  that bronchiectasis progresses with increasing speed
in  patients with NTM pulmonary infection. In several stud-
ies  bronchiectatic lesions and multiple pulmonary nodules
specially in RML and lingula proved to be an important char-
acteristic  of NTM, and it is estimated to be present in over 50%
or  even two third of NTM patients.4,7,9
According to Chung et al. in 2006, bronchiectasis is widely
reported in NTM and multiple cavities are more  reported in
MDR-TB.7 Furthermore, in a study in Iran in 2003 by Zahirifard
et  al., multiple cavities turned out as important characteristic
of  MDR-TB since TB bacilli can settle there rising the risk of
MDR-TB.12
It is told that multiple cavities are even more  common
in MDR-TB than in drug-sensitive TB: 40% in MDR-TB ver-
sus  11% in drug-sensitive TB according to a study.13 In this
study  multiple cavities were more  common in MDR-TB, but
neither  statistically signiﬁcant nor differentiating. This differ-
ent  result is probably caused by long delay of NTM species
diagnosis and can manifest that multiple cavities can also
be  produced by NTM in case of chronic illness without any
b r a z j i n f e c t d i s . 2 0 1 3;1 7(2):137–142  141
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ppropriate treatment. Anyway, it seems that shape and dis-
ribution  of cavities are more  differentiating and reliable factor
ecause  NTM causes thin wall cavities mostly with satel-
ite  nodules in the related segment, but MDR-TB cavities are
ostly  lying within pulmonary consolidation with thick walls.
Martinez  et al. believe that due to slower progression of dis-
ase,  cavities seen in NTM are smaller and have thinner wall in
omparison with post-primary TB.14 Likewise similar study by
urrill et al. demonstrated that cavities found in post-primary
B  usually happen in case of pulmonary consolidation and
ave  irregular thick walls.11
This study also suggests similar conclusion about MDR-TB
atients since most of enrolled patients as MDR-TB had his-
ory  of treatment or previous TB. There was  not any cavitary
onsolidation in our NTM group while almost half of MDR-TB
ases  had it. Another study demonstrated that the appear-
nce  of cavitary consolidation in MDR-TB patients who were
or  at least one month on anti-TB treatment strongly suggests
eactivation of TB.15 In both groups multiple cavities were
ore  common than single, but with more  homogenous lobar
istribution  in NTM patients versus superior lobes involve-
ent  specially RUL in MDR-TB due to the pathogenicity of
ycobacterium tuberculosis in superior lobes and segments.
e  found consolidation in all lobes in both groups, but no
riority  in terms of morbidity rate. Likewise, no signiﬁcant
ifference in this aspect was  obtained in a study compar-
ng  imaging ﬁndings between NTM and drug-sensitive TB.9
his comparison can also be generalized to MDR-TB since
Fig. 6 – Loculated hydropneumothorax.lobes bronchiectasis.
consolidation is seen in both MDR-TB and drug-sensitive TB
with  no signiﬁcant difference.12,16
There was  not any signiﬁcant difference regarding pleu-
ral  effusion despite being more  common in MDR-TB. Other
studies  mentioned that pleural effusion does not commonly
occur  in NTM9 and even TB should be considered immedi-
ately after ﬁnding pleural effusion in imaging17 particularly
because it is one of the most common manifestations in MDR-
TB  too.12
In our study pleural thickening was seen much  more  com-
mon  in MDR-TB cases than NTMs. In general the pleura
thickens gradually in post-primary TB and it can even lead to
tuberculosis empyema  and bronchopleural ﬁstula.11 If pleu-
ral  thickening occurs in NTM, it is mostly seen in the apices
and  also in presence of cavitation.18 Remission of tuberculosis
lesions leaves ﬁbrotic scars and calciﬁcation and, ultimately
pulmonary volume loss.19 In pulmonary TB, lymph node calci-
ﬁcation  following infection and inﬂammation mostly occurs in
thoracic and abdominal lymph nodes and to some extent it is a
common ﬁnding which can be single or multiple, semi lateral
or  bilateral.20 Unfortunately, few studies are conducted com-
paring  ﬁbrotic changes and calciﬁcation in these two diseases.
We  found in this study that lymph nodes and parenchymal tis-
sue calciﬁcation, ﬁbrodestruction and subsequent pulmonary
volume  loss is more  common in MDR-TB and lesser ﬁbrotic
changes  were seen in NTM.
Conclusion
In spite of lots of imaging similarity between two groups of
MDR-TB  and NTM, some radiologic ﬁndings in AFB-positive
patients with failure to respond to ﬁrst line anti-TB treatment
can  help in earlier differentiation between these two groups.
Multiple  thick wall cavities dominant in superior lobes, espe-
cially  if occurring within parenchymal consolidation with
simultaneous chronic changes like ﬁbrodestruction and vol-
ume  loss and calciﬁed parenchyma and pleural thickening
strongly suggest MDR-TB while bronchiectasis in middle lobes
specially  RML and also in RLL and coexistence of multiple thin
wall  cavities uniformly scattered in the lungs with satellite
nodules strongly suggest NTM infection, particularly when
there  is not any evidence of chronicity in parenchyma and
pleura  and mediastinum.
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